The Netherlands
Sencure, established in 2021 and headquartered in The Netherlands, is an emerging player in the Health Care sector, particularly in Medical Devices. Specializing in integrated biosensor technology, Sencure develops chips designed to measure electrophysiological parameters innovatively and minimally affect patient lifestyles.
Pushing forward the possibilities of wearable health tech, Sencure's mission lies in enhancing patient compliance without compromising on technological advancement. By deeply understanding the needs of both healthcare providers and their patients, the company aims to transform wearable health solutions.
Notably, Sencure secured a €5.00M Series A investment on 20 July 2023, with backing from Cottonwood Technology Fund. This financial endorsement reflects investor confidence in its commercial potential and innovative merits.
For investors, Sencure represents a compelling opportunity within the dynamic intersection of healthcare innovation and wearable tech, poised to reshape patient monitoring and care.
